Lingraphica

Lingraphica's journey began in 1983 when Dr. Richard Steele and his colleagues initiated pilot studies exploring the potential of computer-based communication systems for individuals with severe aphasia. These early research endeavors showed significant promise, capturing the attention of a group of investors who decided to seed the company, officially giving birth to Lingraphica in 1990. The following year, 1991, marked a significant milestone as the first Lingraphica speech-generating device was sold. This was also the year the device received approval from the Veteran's Administration, making it accessible to eligible veterans.

A pivotal moment in Lingraphica's history arrived in 2001 when its speech-generating devices became Medicare reimbursable. This development dramatically increased accessibility for countless stroke and aphasia survivors. Driven by a mission to provide hope and improve the quality of life for adults with aphasia and verbal apraxia, Lingraphica continued to innovate. In 2009, the company launched the SmallTalk app series, further expanding the reach of its technology. The introduction of the TouchTalk device followed in 2011. Lingraphica has consistently focused on creating clinically relevant tools and services, working in partnership with clinicians and caregivers. Their commitment extends to providing ongoing support and resources, aiming to meet individuals wherever they are on their journey to regain or improve their communication skills. Over the years, Lingraphica has established itself as a leading provider of communication devices and apps for people with aphasia, a communication disorder that affects a person's ability to process and use language. The company has also been instrumental in research that challenged long-held beliefs about the recovery window for aphasia, demonstrating that individuals can continue to make significant improvements with the right tools and methods.